Table 4 Types of interests covered under current publicly available disclosure requirements

Employment

Recent, continuing, or planned pharmaceutical industry employment

Employment with advocacy organization

“Employment or other professional relationship with any entity directly involved in the production, manufacture, distribution or sale of medicinal products, or directly representing the interest of any such entity in the past 5 years.” [29] (Blood Technical Advisory Committee, Bhutan)

“Any employment in a company or organization that may have relevance to the jurisdiction of NMRA including membership of advisory board in the last 5 years or likely to be forthcoming.” (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)

“Employment.. . in an entity involved in procurement dealings” [27] (Tender Evaluation Committees, Nepal)

Financial relationships

Business dealings

Consultancy

Paid speaker

Paid expert

“Dealings with any company or undertaking which engages in manufacturing, importation, distribution or sale of medicines” [30] (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)

“Paid employment including consultancy, commission, paid speaker, paid expert advisor over the past 5 years or likely to be forthcoming” (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)

Ownership or investment

Ownership

Shares or stocks

Self-managed superannuation (pension) fund

Partnerships

“Direct, indirect. .. interest in any of the parties participating in the bidding” [35] (Tender Evaluation Committees, Bhutan)

“Any other direct or indirect financial interest, example other investments, partnerships plus ownership or a patent for a therapeutic good ownership by employer, investments in self-managed superannuation fund over the past 5 years, or likely to be forthcoming” (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)

“Personal or business interests” [25] (Tender Evaluation Committees, Bangladesh)

“Encouragement to engage in trade or employment in an area over which the public servant has jurisdiction; encouragement to construct, buy or sell property or speculate in investments by someone involved in procurement” [25] (Tender Evaluation Committees, Bangladesh)

“Financial interest (personal or familial) in an entity involved in procurement dealings” [27] (Tender Evaluation Committees, Nepal)

Board membership

Company board membership

Advisory board membership

“Shareholdings, executive or non-executive board memberships over the past 5 years or likely to be forthcoming” (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)

Education

Fellowship

Research or education grants

Student support

“Fellowship, research or education grants over the past 5 years, or likely to be forthcoming” (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)

“Provision by such a company organization of ad hoc support for a patient or student in the last 5 years are likely to be forthcoming.” (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)

Travel

Paid travel (flights, train, hotel)

Conference registration

Invitations to travel or attend training abroad

“Travel plan or conference fee.. .greater than USD $100 over the past 5 years or likely to be forthcoming” (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)

“Invitations to visit a foreign country or train abroad” [25] (Tender Evaluation Committees, Bangladesh)

Gifts

Monetary gifts or rewards

Hospitality

Favours or consideration

Meetings or entertainment in honour of the public servant

Offers of foreign awards, titles, or honours

“Any bribe, consideration, gift, reward, favor or any material or immaterial benefit or any other advantage” [35] (Tender Evaluation Committees, Bhutan)

“Hospitality greater than USD $100 over the past 5 years or likely to be forthcoming” (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)

“Gifts (except those of small intrinsic value); hospitality, meetings or entertainment to honour or praise the public servant; offers of foreign awards, titles or decorations” [25] (Tender Evaluation Committees, Bangladesh)

Family interests

Family or friend ownership or investment

“Private interests. Family’s interests” [2] (Drug Technical Advisory Committee, Bhutan)

“Familial interest in any of the parties participating in the bidding” [35] (Tender Evaluation Committees, Bhutan)

“A friend or a relation or a financial investment in a business involved in the public procurement transaction” [25] (Tender Evaluation Committees, Bangladesh)

Clinical trial involvement

Receipt of research funding or grants

Principal investigator on a trial under consideration

“Participation in clinical trials with as principal investigator, contributor of patient or otherwise, involvement as a researcher or in any other capacity in relation to therapeutic goods, or their development in the last 5 years are likely to be forthcoming” (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)

Intellectual property

Patents

Royalties

“Ownership or a patent for a therapeutic good owned by employer” (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)

Other

Anything else

“Please list any of the interests of the kind, such that if you were to be appointed as a member of the NMRA, a description conflict might arise in relation to matters that could come before the authority” (National Medicines Regulatory Authority, National Advisory Committee, Medicines Evaluation Committee, Sri Lanka)